Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
»
Topics
»
News
» Clinical Intelligence
Clinical Intelligence
RSS
Lexicon’s LX4211 trial shows positive results
September 13, 2011
CenterWatch Staff
Marshall Edwards initiates phase I ME-143 trial
September 9, 2011
CenterWatch Staff
The CenterWatch Monthly, September 2011
September 1, 2011
CenterWatch Staff
Aterena Zentaris’ AGHD study shows favorable results
August 30, 2011
CenterWatch Staff
AiCuris’ Letermovir receives Fast Track designation
August 29, 2011
CenterWatch Staff
Life Extension begins recruitment for Alzheimer’s trial
August 25, 2011
CenterWatch Staff
FDA approves Shire’s FIRAZYR
August 25, 2011
CenterWatch Staff
Bayer’s Radium-223 granted Fast Track Designation
August 23, 2011
CenterWatch Staff
Delcath’s phase II liver cancer trial shows promising results
August 22, 2011
CenterWatch Staff
FDA accepts Alexza’s Adasuve NDA
August 19, 2011
CenterWatch Staff
Previous
1
2
…
127
128
129
130
131
132
133
134
135
…
166
167
Next
Upcoming Events
02
May
Revisiting the FDA’s Proposed Single IRB Mandate: Navigating Changes and Aligning for Success
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
23
May
Maximizing Trial Success Requires Evolving Feasibility and Recruitment Strategies
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here